Skip to main content

Table 1 Characteristics of the patients with and without deep vein thrombosis

From: Prediction of deep vein thrombosis by ultrasonography and D-dimer in Asian patients with ischemic stroke

 

DVT (+)

n = 38

DVT (−)

n = 251

p-value

Age (years)

71 ± 12

68 ± 11

0.058

Male

15 (39.5%)

160 (63.7%)

0.004

Hypertension

30 (78.9%)

178 (71.2%)

0.321

Diabetes

15 (39.5%)

72 (28.8%)

0.182

Hyperlipidemia

23 (60.5%)

172 (68.8%)

0.310

Smoking

14 (36.8%)

116 (48.4%)

0.270

Previous stroke

6 (15.8%)

39 (15.5%)

0.968

Peripheral artery disease

16 (42.1%)

92 (36.7%)

0.517

Active cancer

4 (1.6%)

1 (2.6%)

0.647

Stroke mechanism

 Large artery atherosclerosis

15 (39.5%)

65 (28.0%)

0.132

 Small vessel disease

8 (21.1%)

87 (34.8%)

 Cardioembolism

6 (15.8%)

31 (12.4%)

 Other determined

1 (2.6%)

1 (0.4%)

 Undetermined

8 (21.1%)

66 (26.4%)

 BMI (kg/m2)

23.9 ± 3.5

23.9 ± 2.6

0.927

 mRS before index stroke

0.1 ± 0.4

0.2 ± 0.7

0.220

 Initial NIHSS

7.4 ± 5.4

4.1 ± 3.3

< 0.001

 NIHSS arm

1.3 ± 1.2

1.0 ± 1.0

0.160

 NIHSS leg

2.0 ± 1.1

0.8 ± 1.0

< 0.001

Laboratory results

 AST (mg/dL)

40 ± 4

41 ± 5

0.732

 ALT (mg/dL)

46 ± 15

45 ± 13

0.428

 BUN (mg/dL)

18 ± 10

17 ± 5

0.342

 Creatinine (mg/dL)

0.8 ± 0.2

0.8 ± 0.4

0.297

 D-dimer (mg/dL)

1.2 ± 2.4

0.8 ± 1.2

0.123

 FDP (μg/mL)

7.3 ± 13.4

5.8 ± 9.0

0.433

 Thrombolysis

2 (5.3%)

12 (4.8%)

0.897

Concomitant antithrombotics

 Single antiplatelet

30 (78.9)

194 (77.3)

0.765

 Dual antiplatelet

4 (10.5)

36 (14.3)

 Anticoagulation

4 (10.5)

21 (8.4)

  1. DVT Deep vein thrombosis, BMI Body mass index, mRS Modified Rankin scale, NIHSS National Institutes of Health Stroke Scale, AST Aspartate aminotransferase, ALT Alanine aminotransferase, BUN Blood urea nitrogen, FDP Fibrinogen degradation product